A Novel Approach to Cardiovascular Health by Optimizing Risk Management (ANCHOR): A Primary Prevention Initiative Examining The Impact Of Global Risk Factor Assessment & Management On Health Care In Nova Scotia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,708
- 试验地点
- 2
- 主要终点
- achievement of targeted mean reductions in overal global risk within patient risk strata Proportion of patients achieving their targeted mean reduction in global risk within risk strata
研究概览
简要总结
Study Purpose and Design
The goal of this study is to improve CVD risk in a primary care adult population, with the following primary objectives
- To improve management of global cardiovascular risk of patients within two primary care practices, thereby improving their overall cardiac health.
- To increase patient compliance with lifestyle aimed at pharmaceutical interventions aimed at decreasing global cardiovascular risk.
Secondary objectives of the study are:
- To examine the utility of a process to improve the management of global cardiovascular risk of patients within two primary care practices.
- To explore the utility of a process that links primary care practices with existing community resources in order to manage cardiac risk factors better among individuals within those primary care practices.
- To determine the economic impact of a global risk assessment and management process within a primary care setting.
详细描述
The Burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the major cause of mortality in the developed world, accounting for almost 40% of all deaths in both the United States and Canada. It represents a substantial financial drain on society and contributes a significant burden to health care systems that are already under strain. Major modifiable risk factors for CVD include elevated blood pressure, cigarette smoking, elevated total plasma cholesterol and low high-density lipoproteins, diabetes, obesity, and sedentary lifestyle, at least one of which is present in 80% of Canadians. Circulatory diseases (particularly heart disease, stroke and hypertension) cost the Nova Scotia health care system an estimated $961 million dollars per year. In Nova Scotia cardiovascular disease kills an estimated 2,900 Nova Scotians every year accounting for nearly 36% of all deaths in the province.
Cardiovascular Disease Prevention in Primary Care Settings
There is strong evidence linking improved risk factors among populations to improved health outcomes, and both epidemiological and community research have illustrated that the bulk of non-communicable diseases (NCDs) such as CVD are preventable, or at least their occurrence can be postponed. Because primary care physicians are most often the first point of contact for individuals in need of health care, general practice is well placed to facilitate change in patients' risk factor status and ensure more effective treatment of risk factors such as hypertension and hyperlipidemia. Currently primary care service delivery is expanding to include a broader network of providers such as nurses, dieticians, and pharmacists to enable more effective risk factor identification and management, and health promotion and disease prevention efforts across the continuum of care.
Nova Scotia Context
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •30 years of age
- •a patient of the primary care practices involved in the study
- •able to provide informed consent
排除标准
- •under the age of 30
- •not a patient of the primary care practices
- •unable to provide informed consent
结局指标
主要结局
achievement of targeted mean reductions in overal global risk within patient risk strata Proportion of patients achieving their targeted mean reduction in global risk within risk strata
时间窗: 12 months
次要结局
- determine the economic impact of a global risk assessment management process within a primary care setting(12 months)
- percentage of patients that reduced at least one risk category from baseline(12 months)